NMR in Pharma
The PIPAc Project - Innovation for Production on Demand in Pharma
Controlling chemical reactions with Artificial Intelligence (AI)
The companies NovAliX, Alysophil, De Dietrich Process Systems and Bruker have joined forces to bring to market a new approach to active pharmaceutical ingredient (API) production. The partnership will leverage its complementary skills to provide a complete, standalone, and location-independent API manufacturing solution to a pharmaceutical company or contract manufacturing organization.
We interviewed each of the partners to learn more about this innovative project.
PIPAc project overview video
Interview Julien Marin, Director Research Services Novalix
Interview Philippe Robin, President Alysophil SAS
Interview Luis Carrillo, Managing Director DeDietrich Pharma & Green Solutions
